CIK 0001515673
- Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272546083
- Phone
- +1 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $127,561
- in 3 filings, $17K under 10b5-1 plans
Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-05 | Crombez Eric EVP and Chief Medical Officer | Sale | −344 | $24.96 | $9K | 111,189 |
| 2026-04-16 | Crombez Eric EVP and Chief Medical Officer | Grant or award | +34,674 | 110,975 | ||
| 2026-04-16 | Crombez Eric EVP and Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +59,952 | 59,952 | ||
| 2026-03-02 | Crombez Eric EVP and Chief Medical Officer | Sale | −7,029 | $22.80 | $160K | 76,301 |
| 2026-03-01 | Crombez Eric EVP and Chief Medical Officer | Grant or award | +11,643 | 83,173 | ||
| 2025-05-05 | Crombez Eric EVP and Chief Medical Officer | Sale | −520 | $39.24 | $20K | 71,530 |
| 2025-04-21 | Crombez Eric EVP and Chief Medical Officer | Sale | −242 | $35.11 | $8K | 71,680 |
| 2025-03-03 | Crombez Eric EVP and Chief Medical Officer | Sale | −8,945 | $42.10 | $377K | 71,922 |
| 2025-03-01 | Crombez Eric EVP and Chief Medical Officer | Grant or award | +16,813 | 65,244 | ||
| 2025-03-01 | Crombez Eric EVP and Chief Medical Officer | Grant or award | +14,971 | 80,215 | ||
| 2025-03-01 | Crombez Eric EVP and Chief Medical Officer | Grant or award · Stock Ooption (Right to Buy) | +30,246 | 30,246 | ||
| 2024-05-02 | Crombez Eric EVP and Chief Medical Officer | Sale | −354 | $43.66 | $15K | 48,431 |
| 2024-04-18 | Crombez Eric EVP and Chief Medical Officer | Sale | −142 | $44.10 | $6K | 48,785 |
| 2024-03-01 | Crombez Eric EVP and Chief Medical Officer | Grant or award | +19,400 | 49,912 | ||
| 2024-03-01 | Crombez Eric EVP and Chief Medical Officer | Sale | −1,238 | $53.76 | $67K | 48,927 |
| 2024-03-01 | Crombez Eric EVP and Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +34,200 | 34,200 | ||
| 2024-03-01 | Crombez Eric EVP and Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +2,351 | 2,351 | ||
| 2023-09-27 | Crombez Eric EVP and Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +2,351 | 2,351 | ||
| 2023-05-01 | Crombez Eric EVP and Chief Medical Officer | Grant or award | +4,658 | 30,512 | ||
| 2023-05-01 | Crombez Eric EVP and Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +8,362 | 8,362 |
Page 1 of 1 · 20 trades